Blood Types and Blood Cells II

Blood Types/Erythrocytes

  • Blood group is determined by the surface antigens on erythrocyte (red blood cell) membranes.

    • ABO Blood Group:

      • Determined by the presence or absence of A and B antigens, which are membrane glycoproteins.

      • Type A: Erythrocytes have antigen A.

      • Type B: Erythrocytes have antigen B.

      • Type AB: Erythrocytes have both A and B antigens.

      • Type O: Erythrocytes have neither antigen.

Antibody Status

  • A person's antigen status dictates their antibody status:

    • Individuals do not have antibodies against their own antigens.

    • Individuals have antibodies against foreign antigens.

    • Type A: Contains anti-B antibodies in plasma.

    • Type B: Contains anti-A antibodies in plasma.

    • Type AB: Contains no antibodies.

    • Type O: Contains both anti-A and anti-B antibodies in plasma.

Rh Factor

  • Rh Blood Type:

    • Presence or absence of Rh factor (antigen D) determines if the blood type is positive (+) or negative (-).

    • Anti-D antibodies typically do not exist until an Rh-negative person is exposed to Rh-positive blood.

    • Blood types are reported together (e.g., AB+ if both A and B antigens, and Rh factor are present).

Clinical Concerns About Blood Types

  • Incompatible transfusions can cause agglutination, where recipient antibodies bind to transfused erythrocytes.

    • This can block blood vessels and lead to tissue damage or hemolysis (rupture of erythrocytes).

Rh Incompatibility and Pregnancy

  • An Rh-negative mother may form anti-D antibodies during childbirth if exposed to Rh-positive blood from the baby.

    • These antibodies can cross the placenta in subsequent pregnancies and cause hemolytic disease of the newborn (anemia, hyperbilirubinemia).

    • Prevention involves administering immunoglobulins to Rh-negative women during pregnancy.

Leukocytes (White Blood Cells)

  • Characteristics:

    • Defense against pathogens, have a nucleus and organelles, but not hemoglobin.

    • Motile and flexible; mostly found in tissues, not just blood.

    • Diapedesis: Process where leukocytes squeeze through blood vessel walls.

    • Chemotaxis: Movement towards chemical signals at infection sites.

Types of Leukocytes

  • Classified as either granulocytes or agranulocytes.

    • Granulocytes: Have visible granules when viewed under a microscope.

    • Neutrophils: Most numerous, multilobed nucleus, phagocytic, number increases in bacterial infections.

    • Eosinophils: 1–4% of leukocytes, bilobed nucleus, reddish granules, involved in allergic reactions and parasitic infections.

    • Basophils: 0.5–1% of leukocytes, bilobed nucleus, blue-violet granules containing histamine and heparin (increase blood vessel diameter and inhibit clotting).

    • Agranulocytes: Smaller granules, not visible microscopically.

    • Lymphocytes: 20–40% of leukocytes, involved in immune response (T-cells manage immune response, B-cells produce antibodies, NK cells attack infected cells).

    • Monocytes: C-shaped nucleus, 2–8% of leukocytes, differentiate into macrophages to phagocytize pathogens.

Leukocyte Changes and Diagnosis

  • Leukopenia: Reduced leukocyte count, increased infection risk.

  • Leukocytosis: Elevated leukocyte count, potential causes include infections or stress.

  • Differential Count: Measures types of leukocytes; important for clinical diagnosis.

Specific Changes in Leukocyte Counts

  • Neutrophilia: Increased neutrphils, often due to bacterial infections, stress.

  • Neutropenia: Decreased neutrophils; can be due to drugs or radiation.

  • Lymphocytosis: Increased lymphocytes, associated with viral infections (e.g. mumps).

  • Monocyte Count Changes: Increase due to chronic inflammation (e.g. tuberculosis).

  • Basophil Count Changes: Increases due to overproduction in bone marrow.

Clinical View: Leukemia

  • A malignancy of leukocyte-forming cells leading to abnormal proliferation of leukocytes.

    • Results in increased abnormal leukocyte count and decreased erythrocyte production, causing anemia and bleeding.

    • Acute Leukemia: Rapid progression, often fatal within months in children and young adults.

    • Chronic Leukemia: Slower progression, more common in middle-aged and older adults.

Platelets (Thrombocytes)

  • Small, membrane-enclosed fragments of cells that lack a nucleus.

    • Important role in blood clotting, normally count between 150,000 to 400,000 per mm³ of blood (30% stored in spleen).

    • Circulate for 8 to 10 days before being broken down and recycled.

Blood group is determined by the surface antigens on erythrocyte (red blood cell) membranes. The determination of blood types is crucial for blood transfusions, organ transplants, and prenatal care.

ABO Blood Group:
  • Determined by the presence or absence of A and B antigens, which are membrane glycoproteins.

    • Type A: Erythrocytes have antigen A on their surface, leading to the presence of anti-B antibodies in plasma.

    • Type B: Erythrocytes possess antigen B, which results in anti-A antibodies being present in the plasma.

    • Type AB: Characterized by the presence of both A and B antigens; individuals with this type do not produce any antibodies against A or B, making them universal recipients in blood transfusions.

    • Type O: Erythrocytes have neither A nor B antigens, and these individuals produce both anti-A and anti-B antibodies, rendering them universal donors.

Antibody Status

A person's antigen status dictates their antibody status, emphasizing the critical balance necessary for safe blood transfusions:

  • Individuals do not have antibodies against their own antigens to prevent agglutination.

  • Individuals produce antibodies against foreign antigens, necessitating cross-matching of blood types prior to transfusions to avoid severe reactions.

Rh Factor
  • Rh Blood Type: Presence or absence of the Rh factor (antigen D) determines if the blood type is reported as positive (+) or negative (-).

  • Rh-positive individuals have the D antigen, while Rh-negative individuals do not.

  • Anti-D antibodies typically do not exist until an Rh-negative person is exposed to Rh-positive blood.

  • Blood types are reported together (e.g., AB+ if both A and B antigens, and Rh factor are present), which is a critical practice in transfusion medicine to prevent hemolytic reactions.

Clinical Concerns About Blood Types
  • Incompatible Transfusions: These can cause agglutination, where recipient antibodies bind to transfused erythrocytes, leading to complications such as hemolysis (rupture of erythrocytes) and potentially fatal reactions.

  • Monitoring and careful matching of donor and recipient blood types are essential to mitigate risks associated with transfusions.

Rh Incompatibility and Pregnancy
  • An Rh-negative mother may form anti-D antibodies during childbirth if she is exposed to Rh-positive blood from her baby, which can cause complications in subsequent pregnancies.

  • Maternal anti-D antibodies can cross the placenta, leading to hemolytic disease of the newborn, which can result in anemia, jaundice, and serious complications for the infant.

  • Prevention: It involves administering immunoglobulins (RhoGAM) to Rh-negative women during and after pregnancy to prevent the formation of antibodies.

Leukocytes (White Blood Cells)
  • Characteristics: Leukocytes play a vital role in the body's immune defense against pathogens. They possess a nucleus and organelles but lack hemoglobin.

  • They are motile and flexible, primarily found in tissues rather than solely circulating in blood.

  • Diapedesis: The process by which leukocytes can squeeze through blood vessel walls to migrate towards sites of infection.

  • Chemotaxis: The ability of leukocytes to move toward chemical signals produced at infection sites, highlighting their importance in the immune response.

Types of Leukocytes
  • Classified as either granulocytes or agranulocytes based on the presence of granules:

    • Granulocytes: Have visible granules when viewed under a microscope.

    • Neutrophils: The most numerous leukocyte type, characterized by a multilobed nucleus; they are primarily phagocytic and increase in number during bacterial infections.

    • Eosinophils: Comprise 1–4% of leukocytes, with a bilobed nucleus and reddish granules, are involved in allergic reactions and fighting parasitic infections.

    • Basophils: Representing 0.5–1% of leukocytes, have a bilobed nucleus and contain blue-violet granules rich in histamine and heparin, promoting inflammation and inhibiting blood clotting.

    • Agranulocytes: (Have smaller granules not visible microscopically.)

    • Lymphocytes: Account for 20–40% of leukocytes and play pivotal roles in the adaptive immune response; T-cells manage the immune response while B-cells produce antibodies, and NK cells target infected cells.

    • Monocytes: Display a C-shaped nucleus and make up 2–8% of the leukocyte count; they differentiate into macrophages, performing phagocytosis of pathogens and debris.

Leukocyte Changes and Diagnosis
  • Understanding leukocyte counts is critical for diagnosing various condition:

    • Leukopenia: Reduced leukocyte count leads to a heightened risk of infections.

    • Leukocytosis: Elevated leukocyte count may indicate infections, stress, or other underlying conditions.

    • Differential Count: A crucial test measuring the various types of leukocytes; provides essential information for clinical diagnosis and management.

Specific Changes in Leukocyte Counts
  • Changes in leukocyte counts can indicate specific health issues:

    • Neutrophilia: Increased neutrophil levels, often a response to bacterial infections or stress.

    • Neutropenia: Decreased neutrophil levels can arise from drugs, radiation, or bone marrow disorders.

    • Lymphocytosis: Increased lymphocytes, frequently associated with viral infections (e.g., mumps, Epstein-Barr virus).

    • Monocyte Count Changes: Elevated monocytes may occur due to chronic inflammatory conditions (e.g., tuberculosis).

    • Basophil Count Changes: Increased numbers may result from overproduction in the bone marrow or allergic responses.

Clinical View: Leukemia
  • A malignancy of leukocyte-forming cells leading to an abnormal proliferation of leukocytes.

  • It results in an increased count of abnormal leukocytes while decreasing erythrocyte production, often causing anemia and a risk of bleeding due to insufficient platelets.

  • Acute Leukemia: Characterized by rapid progression and often fatal within months, particularly affecting children and young adults.

  • Chronic Leukemia: Progresses more slowly, more common in middle-aged and older adults, and may often be asymptomatic initially.

Platelets (Thrombocytes)
  • Small, membrane-enclosed cell fragments that lack a nucleus but play a crucial role in hemostasis (blood clotting).

  • Normal platelet counts range between 150,000 to 400,000 per mm³ of blood, with approximately 30% stored in the spleen.

  • They circulate for 8 to 10 days before being broken down and recycled through the spleen and liver, emphasizing their dynamic role in maintaining hemostatic balance and responding to vascular injury.

Agglutination is the process where antibodies bind to specific antigens on the surface of erythrocytes (red blood cells), causing them to clump together. This phenomenon can occur during incompatible blood transfusions, where recipient antibodies recognize transfused erythrocytes as foreign due to the presence of different antigens. The clumping caused by agglutination can block blood vessels, leading to tissue damage and potential rupture of erythrocytes (hemolysis). Ensuring proper blood type matching before transfusions is critical to prevent agglutination.